Kanazawa University, report in Small, on how short peptides self-assemble linearly on atomically-thick solid surfaces, such ...

The company has integrated the AI model into its internal discovery pipeline and aims to use it in collaborative drug ...

Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis.